Trials / Completed
CompletedNCT04721847
Pain Neuroscience Education in Diabetic Neuropathy
Effects of Pain Neuroscience Education in Diabetic Neuropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effects of Pain Neuroscience Education in Diabetic Neuropathy
Detailed description
Pain neuroscience education (PNE) has shown to have immediate effects on various clinical signs and symptoms associated with central sensitization. Using a model of (innocuous, noxious and allodynia) PNE can be used in combination with exercise therapy, especially treating patients in which the nervous system has become increasingly hypervigilant. Teaching patients about the neuroscience of pain and lead to healthier and more positive attitudes and beliefs regarding chronic pain. Pain in diabetic neuropathy restrict the activity participation and compromise their quality of life. PNE will be helpful in such patients so decreasing pain can improve their quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pain Neuroscience Education | In first part educational content will be designed to be given in group of patients in six sessions by PNE booklet. The six sessions are 1.5 hours long (9 hours) and will be given at a frequency of 1 session per week. Final session will be given to solve doubts, and to provide additional information to the educational program. Book for additional material will be delivered to participants. |
| OTHER | Conventional Physical therapy | Control group will be treated by Conventional Physical therapy like TENS, stretching and strengthening exercises. Intervention will be initiated with warm up period (joint mobility exercises) for the duration of 5 mins and ended up with cool down period (relaxing exercises i.e. deep breathing) for the duration of 5 mins. |
Timeline
- Start date
- 2020-08-13
- Primary completion
- 2021-07-28
- Completion
- 2021-08-31
- First posted
- 2021-01-25
- Last updated
- 2021-09-23
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04721847. Inclusion in this directory is not an endorsement.